<ѻý>Wegovy Cut Albuminuria by Half in Non-Diabetic CKDѻý> However, 24 weeks of the GLP-1 had no impact on eGFR Oct 29, 2024
<ѻý>Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patientsѻý> Findings leave researcher "concerned" Oct 23, 2024
<ѻý>Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kidsѻý> News and commentary from the endocrinology world Oct 22, 2024
<ѻý>Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancerѻý> News and commentary from the endocrinology world Oct 15, 2024
<ѻý>Weekend Warrior Benefits; Time-Restricted Eating and Metabolic Syndromeѻý> Also in TTHealthWatch: menopause hormone therapy in the U.S. Oct 12, 2024 podcast
<ѻý>Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementiaѻý> News and commentary from the endocrinology world Oct 08, 2024
<ѻý>Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equationѻý> Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
<ѻý>Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1Dѻý> News and commentary from the endocrinology world Oct 01, 2024
<ѻý>One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Pubertyѻý> News and commentary from the endocrinology world Sep 24, 2024
<ѻý>GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Deathѻý> Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
<ѻý>Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screeningѻý> More noteworthy research from the EASD 2024 meeting Sep 13, 2024
<ѻý>Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6ѻý> Saxenda group six times more likely to lose at least 5% of BMI Sep 10, 2024
<ѻý>FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Winѻý> News and commentary from the endocrinology world Sep 09, 2024
<ѻý>Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympicsѻý> News and commentary from the endocrinology world Sep 03, 2024
<ѻý>T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Availableѻý> News and commentary from the endocrinology world Aug 27, 2024
<ѻý>Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Updateѻý> News and commentary from the endocrinology world Aug 20, 2024
<ѻý>Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Ligninsѻý> News and commentary from the endocrinology world Aug 13, 2024
<ѻý>Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMIѻý> News and commentary from the endocrinology world Aug 06, 2024
<ѻý>Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushbackѻý> News and commentary from the endocrinology world Jul 30, 2024
<ѻý>Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issuesѻý> News and commentary from the endocrinology world Jul 23, 2024
<ѻý>People Without Diabetes Make Up Growing Share of GLP-1 Usersѻý> Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
<ѻý>Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Downѻý> News and commentary from the endocrinology world Jul 16, 2024
<ѻý>New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Bannedѻý> News and commentary from the endocrinology world Jul 09, 2024
<ѻý>Tirzepatide Bests Semaglutide for Real-World Weight Lossѻý> Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
<ѻý>CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabeticsѻý> News and commentary from the endocrinology world Jul 01, 2024
<ѻý>First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warningѻý> News and commentary from the endocrinology world Jun 25, 2024
<ѻý>Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2Dѻý> Insulin sensitivity also improved in people with obesity free of diabetes Jun 23, 2024
<ѻý>Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Lossѻý> News and commentary from the endocrinology world Jun 18, 2024
<ѻý>Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testingѻý> News and commentary from the endocrinology world Jun 11, 2024
<ѻý>Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ...ѻý> Analysis of patients with obesity and diabetes only looked at first-generation GLP-1 agonists Jun 07, 2024
<ѻý>ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risksѻý> More research from the Endocrine Society's annual meeting Jun 05, 2024
<ѻý>Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Txѻý> News and commentary from the endocrinology world Jun 03, 2024
<ѻý>Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24ѻý> Percentage weight loss is in line with pivotal trial results using standard obesity thresholds May 31, 2024
<ѻý>How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use?ѻý> News and commentary from the endocrinology world May 28, 2024
<ѻý>Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelinesѻý> News and commentary from the endocrinology world May 14, 2024
<ѻý>Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Billѻý> News and commentary from the endocrinology world May 07, 2024
<ѻý>Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigationѻý> News and commentary from the endocrinology world Apr 30, 2024
<ѻý>New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage Onѻý> News and commentary from the endocrinology world Apr 23, 2024
<ѻý>Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?ѻý> News and commentary from the endocrinology world Apr 16, 2024
<ѻý>Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonistsѻý> Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024